<DOC>
	<DOCNO>NCT01214148</DOCNO>
	<brief_summary>A prospective , single-treatment , multi centre clinical trial enrol 30 patient 2 centre Romania , clinical angiographic follow-up 4 9 month determine primary endpoint late lumen loss secondary endpoint . A subgroup 15 patient also undergo post implantation , 4 9 month IVUS examination . Additional clinical follow-up take place 1 month yearly three ( 3 ) year . The objective trial ass safety clinical performance ORSIRO drug elute stent patient single de-novo coronary artery lesion .</brief_summary>
	<brief_title>First Man Experience With Drug Eluting Stent De Novo Coronary Artery Lesions</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>1 . Patient ≥18 year old ; 2 . Clinical evidence ischemic heart disease / positive functional study . Documented stable angina pectoris ( Canadian cardiovascular society classification ( CCS ) 1 , 2 , 3 4 ) , document silent ischemia ; 3 . Single de novo lesion ≥50 % &lt; 90 % stenosis 1 coronary artery ; 1 . Documented leave ventricular ejection fraction ( LVEF ) ≤30 % ; 2 . Unstable angina pectoris ( Braunwald Class A IIII ) 3 . Threevessel coronary artery disease 4 . Evidence myocardial infarction within 72 hour prior index procedure ; 5 . Known allergy follow : Acetylsalicylic acid ( ASA ) ( Aspirin® ) , Clopidogrel bisulfate ( Plavix® . ) Ticlopidine ( Ticlid® . ) , Heparin , contrast agent ( adequately premedicated ) , cobaltchromium ( CoCr ) , PolyLLactidic Acid ( PLLA ) , silicon carbide ( aSiC : H ) 6 . A platelet count &lt; 100.000 cells/mm3 &gt; 700.000 cells/mm3 WBC &lt; 3.000 cells/mm3 ; 7 . Acute chronic renal dysfunction ( serum creatinine &gt; 2.0 mg/dl &gt; 150µmol/L ) ; 8 . Total occlusion ( TIMI 0 1 ) ; 9 . Target vessel evidence thrombus excessively tortuous make unsuitable proper stent delivery deployment ; 10 . Significant ( &gt; 50 % ) stenosis proximal distal target lesion might require revascularization impede run ; 11 . Heavily calcified lesion and/or calcify lesion successfully predilated ; 12 . Target lesion locate supply arterial venous bypass graft ; 13 . Ostial target lesion ( within 5.0mm vessel origin ) ; 14 . Target lesion involves side branch &gt; 2.0mm diameter ; 15 . Unprotected Left main coronary artery disease ( stenosis &gt; 50 % ) ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>